SDV

3.39%

61.0¢ scidev ltd

Ann: Quarterly Report and Appendix 4C, page-13

First 13 Last

Share
Profile

Follow
PrivateRob

2,070 Posts.

263

14/10/20

14:54

Post #: 48089561
Share

Originally posted by Logic[Al]: ↑

Whilst I hold in anticipation of some strong catalysts, my original concerns regarding margins remain.
500k NPBT from $9.4mill revenue does not read excitingly but it does represent a more positive wider picture that the company has been able to remain cash flow positive a few quarters in a row.

Once the company grows inorganically through an acquisition in the water vertical, I assume we’ll grow our revenues but it may take a little longer to economise the introduction of that as well as HFT and ProSol.

We have a lot of trials on the go and some significant momentum with revenue growth (even if it has been mostly inorganic) but we just need to get a little further down the economies of scale curve to really start seeing the benefits and justifying our market cap. If we could net ~$6mill FY21, I’d be very happy with the progress.

We raised $7mill minus fees last quarter yet finished with a similar cash balance to the start of the quarter. I know we need money to make money and that aggressive growth requires investment but I’m just wary of further dilution if we can’t begin to add to our cash balance from organic growth. I’m not saying the company won’t ‘make it’, I’m just saying that at this rate it might take a little longer for shareholders to reap the capital returns.

then again, the sp is based on sentiment and the market seems to focus on revenue more than net profit at times. Here’s to hoping that’s the case here too

Expand

Strong catalysts such as Syncrude - $1m of product for a 2-week trial ... so could be $15-20m for the year?

A lot of money being spent up front on establishing deals, which I am comfortable with.

Some very promising comments in here. Exciting next few months. Imo.

SDV Price at posting: 75.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 21 more messages in this thread...

First 13 Last

Add SDV (ASX) to my watchlist

(20min delay)
Last 61.0¢		Change 0.020(3.39%)		Mkt cap ! $115.7M

Open	High	Low	Value	Volume
59.5¢	61.0¢	59.0¢	$23.29K	39.11K

Buyers (Bids)

No.	Vol.	Price($)
2	2523	59.5¢

Sellers (Offers)

Price($)	Vol.	No.
62.5¢	5000	1

View Market Depth

No.	Vol.	Price($)
2	2523	0.595
2	23890	0.590
1	32500	0.585
3	63500	0.580
2	59200	0.575

Price($)	Vol.	No.
0.625	5000	1
0.630	31814	3
0.640	52095	2
0.645	25000	1
0.650	55770	2

Last trade - 15.27pm 04/10/2024 (20 minute delay)

SDV (ASX) Chart

Ann: Quarterly Report and Appendix 4C, page-13

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Report and Appendix 4C, page-13

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News